Pharma major Lupin today said it has received an establishment inspection report (EIR) from the USFDA on closure of inspection of its Mandideep and Aurangabad facilities.
In a BSE filing, Lupin said: “It has received establishment inspection report (EIR) for its Mandideep and Aurangabad facilities wherein the USFDA has concluded that the inspections stand closed.”
{iframe}http://health.economictimes.indiatimes.com/news/pharma/lupin-receives-eir-report-from-usfda-on-inspection-closure/52475148{/iframe}